Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertrophy, Left Ventricular | 3 | 2011 | 45 | 0.610 |
Why?
|
| Hypertension | 5 | 2011 | 835 | 0.560 |
Why?
|
| Heart Failure | 4 | 2007 | 302 | 0.550 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2004 | 96 | 0.370 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 1999 | 30 | 0.290 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 247 | 0.270 |
Why?
|
| Nitric Oxide Synthase | 2 | 2005 | 135 | 0.260 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2002 | 22 | 0.260 |
Why?
|
| Isosorbide Dinitrate | 1 | 2007 | 9 | 0.260 |
Why?
|
| Nitric Oxide Donors | 1 | 2007 | 41 | 0.250 |
Why?
|
| Nitric Oxide | 2 | 2007 | 386 | 0.250 |
Why?
|
| Stroke Volume | 3 | 2002 | 122 | 0.250 |
Why?
|
| Ventricular Remodeling | 1 | 2007 | 61 | 0.240 |
Why?
|
| Echocardiography, Doppler | 3 | 2002 | 41 | 0.230 |
Why?
|
| Echocardiography | 3 | 2011 | 167 | 0.170 |
Why?
|
| Cardiac Output | 1 | 1999 | 24 | 0.150 |
Why?
|
| Blood Pressure | 3 | 2011 | 666 | 0.150 |
Why?
|
| Physical Exertion | 1 | 1999 | 27 | 0.150 |
Why?
|
| Coronary Angiography | 2 | 2011 | 96 | 0.140 |
Why?
|
| Myocardial Ischemia | 1 | 1999 | 83 | 0.140 |
Why?
|
| Ventricular Function, Left | 1 | 1999 | 114 | 0.140 |
Why?
|
| Heart Ventricles | 1 | 1998 | 123 | 0.130 |
Why?
|
| Exercise | 1 | 2002 | 692 | 0.120 |
Why?
|
| Middle Aged | 10 | 2011 | 12222 | 0.110 |
Why?
|
| Aged | 7 | 2011 | 8214 | 0.110 |
Why?
|
| Diastole | 3 | 2004 | 47 | 0.100 |
Why?
|
| Male | 11 | 2011 | 23409 | 0.100 |
Why?
|
| Systole | 3 | 2004 | 67 | 0.100 |
Why?
|
| Endothelium, Vascular | 2 | 2005 | 263 | 0.090 |
Why?
|
| Risk Factors | 4 | 2011 | 3994 | 0.090 |
Why?
|
| Multivariate Analysis | 2 | 2011 | 638 | 0.090 |
Why?
|
| Female | 10 | 2011 | 24698 | 0.090 |
Why?
|
| Humans | 14 | 2011 | 43102 | 0.080 |
Why?
|
| Adult | 7 | 2011 | 13872 | 0.080 |
Why?
|
| Exercise Test | 2 | 2002 | 74 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2011 | 2544 | 0.080 |
Why?
|
| Chest Pain | 1 | 2011 | 49 | 0.080 |
Why?
|
| Coronary Vessels | 1 | 2011 | 92 | 0.080 |
Why?
|
| Electrocardiography | 1 | 2011 | 185 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2005 | 75 | 0.070 |
Why?
|
| Superoxides | 1 | 2007 | 57 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 234 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 2853 | 0.060 |
Why?
|
| Coronary Artery Disease | 2 | 2005 | 163 | 0.060 |
Why?
|
| Registries | 2 | 2005 | 437 | 0.060 |
Why?
|
| Simvastatin | 1 | 2005 | 29 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2007 | 375 | 0.060 |
Why?
|
| Coronary Circulation | 1 | 2005 | 29 | 0.060 |
Why?
|
| Dyslipidemias | 1 | 2005 | 48 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2005 | 734 | 0.050 |
Why?
|
| Alleles | 1 | 2005 | 352 | 0.050 |
Why?
|
| Confidence Intervals | 2 | 2005 | 162 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 455 | 0.050 |
Why?
|
| Blood Flow Velocity | 2 | 2004 | 87 | 0.050 |
Why?
|
| Education, Medical | 1 | 2005 | 118 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2005 | 243 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2005 | 208 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2005 | 269 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2002 | 100 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 310 | 0.040 |
Why?
|
| Cardiovascular Diseases | 2 | 2006 | 749 | 0.040 |
Why?
|
| Prognosis | 2 | 2005 | 861 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2005 | 863 | 0.040 |
Why?
|
| Gated Blood-Pool Imaging | 1 | 1999 | 2 | 0.040 |
Why?
|
| Cardiac Output, Low | 1 | 1999 | 2 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2005 | 706 | 0.040 |
Why?
|
| Rest | 1 | 1999 | 32 | 0.040 |
Why?
|
| Exercise Tolerance | 1 | 1999 | 22 | 0.040 |
Why?
|
| Death | 1 | 1998 | 11 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 1081 | 0.040 |
Why?
|
| Heart Transplantation | 1 | 1998 | 47 | 0.040 |
Why?
|
| Regression Analysis | 1 | 1999 | 490 | 0.030 |
Why?
|
| Survival Rate | 1 | 1998 | 355 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 1999 | 575 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 1999 | 236 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 1998 | 1067 | 0.030 |
Why?
|
| Risk Assessment | 1 | 1998 | 863 | 0.030 |
Why?
|
| Georgia | 2 | 2005 | 192 | 0.030 |
Why?
|
| Comorbidity | 2 | 2005 | 737 | 0.020 |
Why?
|
| Primary Health Care | 2 | 2005 | 380 | 0.020 |
Why?
|
| Medical Audit | 1 | 2006 | 26 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2005 | 36 | 0.010 |
Why?
|
| Internal Medicine | 1 | 2005 | 32 | 0.010 |
Why?
|
| Group Practice | 1 | 2005 | 8 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 73 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2005 | 224 | 0.010 |
Why?
|
| Age Distribution | 1 | 2005 | 249 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2005 | 81 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2005 | 110 | 0.010 |
Why?
|
| Vasodilation | 1 | 2004 | 64 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2004 | 123 | 0.010 |
Why?
|
| Community Networks | 1 | 2005 | 107 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2004 | 206 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2005 | 146 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 223 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2005 | 161 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2005 | 587 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2005 | 235 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 201 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2005 | 169 | 0.010 |
Why?
|
| Community Health Services | 1 | 2005 | 206 | 0.010 |
Why?
|
| Curriculum | 1 | 2005 | 318 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 719 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 287 | 0.010 |
Why?
|
| Logistic Models | 1 | 2005 | 1009 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 800 | 0.010 |
Why?
|
| Prevalence | 1 | 2005 | 1612 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 2000 | 13 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2005 | 1604 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2000 | 23 | 0.010 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2000 | 26 | 0.010 |
Why?
|
| Mitral Valve | 1 | 2000 | 36 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2005 | 609 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2005 | 539 | 0.010 |
Why?
|
| Minority Groups | 1 | 2005 | 690 | 0.010 |
Why?
|
| Diet | 1 | 2005 | 826 | 0.010 |
Why?
|
| Smoking | 1 | 2005 | 1024 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2005 | 3156 | 0.010 |
Why?
|
| Adolescent | 1 | 2004 | 6081 | 0.010 |
Why?
|